IL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells

Immunology Letters

Volumn 120, Issue 1-2, 2008, Pages 103-107

  Song, Hyunkeun ^a   Kim, Kyung Eun ^b   Hur, Daeyoung ^a   Lim, Jong Seok ^b   Yang, Young ^b   Cho, Byung Joo ^c   Kim, Cherl hyun ^d   Kim, Taesung ^e   Bang, Saic ^f   Lee, Wang Jae ^g   Park, Hyunjeong ^h   Cho, DaeHo ^b  

^a Inje University College of Medicine   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Dankook University   (South Korea)

^e Korea University   (South Korea)

^f Sungkyunkwan University   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

^h The Catholic University of Korea   (South Korea)

Author keywords

IL 18; Natural killer cells; NKG2D; Tumor immunity; ULBP

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BINDING PROTEIN; INTERLEUKIN 18; LIGAND; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN ULBP2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTHRACENES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; JURKAT CELLS; LEUKEMIA; MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 50449084622     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.07.007     Document Type: Article

References (30)

1. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5 (2004) 996-1002
2. Trinchieri G. Biology of natural killer cells. Adv Immunol 47 (1989) 187-376
3. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 190 (1999) 1505-1516
4. Vivier E., Nunes J.A., and Vely F. Natural killer cell signaling pathways. Science 306 (2004) 1517-1519
5. Pende D., Cantoni C., Rivera P., Vitale M., Castriconi R., Marcenaro S., et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 31 (2001) 1076-1086
6. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
7. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62 (2002) 6178-6186
8. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., and Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2 (2001) 255-260
9. Welte S.A., Sinzger C., Lutz S.Z., Singh-Jasuja H., Sampaio K.L., Eknigk U., et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33 (2003) 194-203
10. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781-790
11. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190
12. Cerwenka A., Baron J.L., and Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 98 (2001) 11521-11526
13. Strong R.K. Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer. Mol Immunol 38 (2002) 1029-1037
14. Lopez-Soto A., Quinones-Lombrana A., Lopez-Arbesu R., Lopez-Larrea C., and Gonzalez S. Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor. J Biol Chem 281 (2006) 30419-30430
15. Eagle R.A., Traherne J.A., Ashiru O., Wills M.R., and Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol 67 (2006) 159-169
16. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
17. Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., and Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10 (1998) 259-264
18. Stoll S., Muller G., Kurimoto M., Saloga J., Tanimoto T., Yamauchi H., et al. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159 (1997) 298-302
19. Telusma G., Datta S., Mihajlov I., Ma W., Li J., Yang H., et al. Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol 18 (2006) 1563-1573
20. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12 (2000) 59-63
21. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 (2004) 15-22
22. Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 172 (1994) 227-239
23. Kubin M., Cassiano L., Chalupny J., Chin W., Cosman D., Fanslow W., et al. ULBP1, 2, 3 novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol 31 (2001) 1428-1437
24. Sekiyama A., Ueda H., Kashiwamura S., Nishida K., Kawai K., Teshima-kondo S., et al. IL-18; a cytokine translates a stress into medical science. J Med Invest 52 (2005) 236-239
25. Yoo J.K., Kwon H., Khil L.Y., Zhang L., Jun H.S., and Yoon J.W. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol 175 (2005) 8280-8286
26. Wyman T.H., Dinarello C.A., Banerjee A., Gamboni-Robertson F., Hiester A.A., England K.M., et al. Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation. J Leukoc Biol 72 (2002) 401-409
27. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93 (1996) 12445-12450
28. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., and Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96 (1999) 6879-6884
29. Rohner A., Langenkamp U., Siegler U., Kalberer C.P., and Wodnar-Filipowicz A. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk Res 31 (2007) 1393-1402
30. Hamerman J.A., Ogasawara K., and Lanier L.L. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 172 (2004) 2001-2005